Echinocytes were frequently found in patients with liver disease when their blood was examined in wet films, but rarely detected in dried, stained smears. When normal erythrocytes (discocytes)
Introduction
The initial assessment of erythrocyte morphology in liver disease is usually based on examination of dried, stained blood films.
Portions of this study were Unfortunately, drying may cause shape artefacts to which wet preparations and scanning electron microscopy (SEM)' are not subject. "Target" cells are common in stained smears from jaundiced patients, but result from distortion because they are codocytic (bell-shaped) in wet films. In 1968, Grahn and colleagues (I) found spiculated erythrocytes in wet blood films from patients with liver disease; they were not evident in dried, stained specimens. This observation has largely been disregarded. They pointed out that these cells (which we shall call echinocytessee Methods) were also present in "spur cell anemia," a hemolytic disorder seen occasionally in severe alcoholic liver disease and characterized by the presence of acanthocytes2 (1) (2) (3) (4) . Acanthocytes are bizarre, irregularly spiculated cells recognizable in stained smears, as well as in wet films. Grahn et al. (1) found that the serum from blood containing echinocytes caused echinocytosis of normal erythrocytes; serum from blood that contained acanthocytes also induced formation of echinocytes, but not of acanthocytes. They therefore argued that an additional factor acting in vivo might be necessary to produce acanthocytes and suggested that the spleen might be involved. They were unable to identify the serum fraction(s) responsible for the formation of echinocytes.
Hui and Harmony (5) produced echinocytes by incubating normal erythrocytes with isolated normal low density lipoproteins (LDL). The active constituent was apparently apolipoprotein B (apoB), inasmuch as cyclohexanedione blockage of the arginine residues of apoB reduced echinocytogenic potency (6) . The high density lipoprotein (HDL) of patients with liver disease is often enriched in apoE, which competes with the apoB of normal LDL for "apoB,E-receptors" on the surface of nucleated cells (7) . We have therefore investigated whether abnormal HDL from jaundiced patients, like normal LDL, would cause echinocytosis. We found echinocytes in patients with liver disease; morphologically similar cells were formed rapidly when normal erythrocytes were incubated with abnormal HDL from these patients. Echinocytosis did not result from addition or extraction of membrane components; the important factor seemed to be reversible, saturable binding of abnormal HDL particles to the erythrocyte surface.
Methods
Patients. HDL were isolated from 18 inpatients with liver disease of varying severity (Table I) (7) . The lipoproteins were used within a day or two of isolation and were passed through a 0.2-mtm filter before addition to erythrocyte suspensions; techniques used for compositional analysis, labeling with 125I, and chemical modification have been described previously (7) .
Erythrocyte isolation, morphology, and analysis. Erythrocytes were separated by centrifugation at 40C of venous blood anticoagulated with 10 U/ml heparin. They were washed three times with Hanks' solution, brought to a hematocrit of '-50% and fixed for 30 min at 0C by adding an equal volume of 1% glutaraldehyde in Hanks' solution. Morphology was examined by light microscopy of wet films and frequently by SEM (Philips 501). When whole blood was fixed, erythrocyte shape appeared identical to that in washed preparations.
Use of SEM has allowed reclassification of erythrocyte shape and a better insight into the relationship between spiculated forms (9) . In liver disease four "spiculated" erythrocyte shapes can be recognized in addition to normal biconcave discs (discocytes). These are discs with protuberances around the edge (echinocytes I), flat cells with spicules over the surface (echinocytes II), spherical or ellipsoidal cells with a large number ofspicules evenly distributed over the surface (echinocytes III), and cells with a bulbous body and a small number of irregularly spaced spicules, generally with knobbly, club-shaped ends (acanthocytes) (Fig. 1) . These shapes may generally be distinguished by light microscopy of wet films, Figure 1 . Scanning electron micrograph of erythrocytes from a patient (M.F., Table I Washed erythrocytes (10% hematocrit) were subjected to proteolysis by incubating for 1 h at 37°C with 0.5 mg/ml of trypsin, chymotrypsin, or pronase in 5 mM sodium phosphate, 150 mM NaCl, pH 7.4. The cells were washed, membranes were prepared, and their protein compositions were analyzed by SDS-gel electrophoresis in 0.1 M Tris-Bicine N,N-bis(2-hydroxyethyl)glycine, pH 8.1 (15). The "dot-blot" technique was used to establish whether binding of patient HDL still occurred; membrane protein was spotted onto washed nitrocellulose, incubated with radioiodinated HDL and the amount of binding measured.
Other studies. For measurement of phosphorylation changes in the spectrin of the membrane cytoskeleton, erythrocytes were prelabeled with 32P (16) Table I ), from whose blood HDL was isolated, were alcoholic cirrhotics with a hemolytic anemia and "spur cells." Acanthocytes were evident by SEM (Fig. I and Fig. 2 C) but comprised only 4-6% of the total erythrocyte population; most cells were echinocytes II or III. Erythrocytes in the other 16 patients showed variable echinocytosis but no acanthocytes in wet films or by SEM; in only two (A.S. and S.F.) were spiculated cells reported on routine examination of dried, stained smears. Light microscopy of wet films allowed discrimination of the various types of echinocytes ( Fig. 3 A) and acanthocytes ( Fig. 3 C) . Like Grahn et al. (1), we found almost no type II or III echinocytes in dried, stained films ( Fig. 3 B) , but acanthocytes were readily recognized (Fig. 3 D) .
In all three patients with abetalipoproteinemia small proportions of acanthocytes were present, but most cells were echinocytes II Fig. 4 ). With some patient HDL, only B I echinocytes I and II were formed (Fig. 4 A) ; with HDL from others (A.S., M.T., and J.R., Table I ) complete conversion to type II or III echinocytes occurred (Fig. 4 B) . The ability of a patient's HDL to transform normal erythrocytes correlated with the proportion of echinocytes in the patient's blood (r = 0.92, P < 0.00 1; Table I ). Less than 1% of normal cells became echinocytes when incubated with HDL from normal subjects. Echinocytosis occurred within the time required to stop the reaction (>5 s); no further changes were seen with incubation for up to 4 h. The degree of echinocytosis was dependent on HDL concentration but independent oftemperature, giving the same result at 0°C and at 37°C after a 1-min incubation (Fig. 5) .
Several patients' VLDL, LDL, HDL, and LPDS were isolated and incubated with normal erythrocytes for I min at 37°C. Only the HDL and LPDS fractions were echinocytogenic at concentrations equal to those in the original plasma. LPDS was much less effective than HDL but may still have contained lipoprotein components, derived artefactually by ultracentrifugation (21) Reversibility of the discocyte-echinocyte transformation. Echinocytes formed in seconds retained their abnormal shape on prolonged incubation (up to 4 h) with the patient HDL, and also showed little reversal after washing and subsequent reincubation in Hanks' solution for up to 8 h. When they were incubated with normal HDL there was complete reversal to normal erythrocyte morphology within seconds (Fig. 6 ). Normal LPDS induced only partial reversal even at high concentrations.
Reversibility of echinocytes found in liver disease. Normal HDL (8 mg/ml) was added to suspensions of erythrocytes from rarely seen in dried smears (B). In a patient with "spur cell" anemia (M.T., Table I ) acanthocytes can be distinguished from echinocytes in wet films (C) and are also recognized in dried films (D).
30 patients with liver disease, whose blood contained at least 10% echinocytes II and III. In each case there was a rapid reduction in the percentage of type II and III echinocytes (Fig. 6 and Fig. 7 ). Complete reversal was rarely achieved, possibly because the cells had adapted to their new morphology during prolonged exposure to the echinocytic agent and reversed only slowly when the agent was removed (22). Excess normal HDL also ameliorated the echinocytosis of cells from the two patients with spur cell anemia but the proportion of acanthocytes was unchanged, suggesting that acanthocytosis was irreversible.
Binding studies. Lipoprotein binding by erythrocytes reached equilibrium within 30 min, but the small number of sites per Fig. 8 ). There appeared to be 4,000-5,000 sites per cell. Defatted albumin reduced the amount of abnormal HDL bound, but a large part was not displaced (Fig. 9) Spectrin and echinocytosis. Phosphorylation of spectrin in the erythrocyte cytoskeleton was unaffected by lipoproteins within the incubation time required for shape changes viz. seconds for abnormal HDL and up to I h for LDL (Fig. 10) . The result for LDL conflicts with that of Hui and Harmony (26) .
Low concentrations of diamide were added to erythrocytes to cause limited thiol oxidation with the formation of cross-links, mainly between spectrin molecules (18). These cells became partially resistant to patient HDL; 45-50% oferythrocytes treated with diamide remained discocytic after addition of abnormal HDL compared to < I0% of untreated cells. The protective effect of diamide was reversed on reduction of the cross-links with dithiothreitol.
Apolipoproteins and echinocytosis. The proportion of apoE in HDL from our 18 patients was higher (I13.2±7.3%, mean±SD, range 4.0-30.0%) than that in HDL from 10 normal subjects (3.9±1.0%, range 2.6-5.4%; P < 0.001), but there was no significant correlation with echinocytogenic potency (r = 0.26, P > 0.05; calculated from Table I ). Agents that prevent apoE binding by apoB,E receptors on nucleated cells, e.g., protamine (200 utg/ml) or heparin (10 mg/ml), or cyclohexanedione modification of apoliprotein arginine residues (7), did not impede echinocytosis. Moreover, discocytes from patients with homozygous familial hypercholesterolaemia, which lack apoB,E receptors, were readily transformed to echinocytes. HDL from three patients with abetalipoproteinemia also contained excess apoE (10.5±0.8%, range 9.6-1 1.1%) but were nonechinocytogenic at concentrations up to 1.5 mg/ml; presumably other factors are more important for echinocytosis in these patients, such as the increased sphingomyelin content (8) in the cell membrane. Two additional, more basic apolipoproteins, previously described (7), were found in HDL from nine of the patients with liver disease, but their presence did not reflect echinocytogenic activity (r = -0.31, P > 0.05).
Relation ofchanges in erythrocyte shape to erythrocyte cholesterol content. Echinocyte formation by patient HDL, as expected from the rapidity of the process, was not accompanied by net cholesterol uptake (Table II) . Furthermore, the lipid content of these echinocytes, and those of patients, did not change on incubation with normal HDL and reversion to normal shape. Figure 6 . Reversibility of echinocytes produced by incubation of normal red cells with HDL isolated from jaundiced patients and of echinocytes found in liver disease. Normal erythrocytes were transformed to echinocytes II and III by HDL from patient A.S. as described in Fig. 4 (A). After washing, these echinocytes were incubated for I min at brane cholesterol by equilibration with cholesterol-rich liposomes ( Fig. 2 F) ; many showed peripheral distortion as in type I echinocytes. Type II echinocytes were rare, and probably resulted from prolonged incubation, in that they also appeared in controls.
Amphipaths and echinocyte formation. Small amounts of amphipathic anions or other ligands cause echinocytosis by partitioning mainly into the outer leaflet of the membrane bilayer and expanding its area relative to the inner leaflet (29-31). We studied two physiologic amphipaths, bile salts and lysolecithin, to determine whether they could be the active components of abnormal HDL. Echinocytosis by bile salts or lysolecithin, and its reversal by addition of normal HDL, was rapid and the echinocytes produced resembled by SEM those generated by patient HDL. However, HDL-induced echinosytosis could not be explained by detectable increases ofthese amphipaths in active HDL; freshly isolated echinocytic HDL contained no more lysolecithin than normal HDL (1-2% of total phospholipid) and had a low total bile acid content (2-9 nmol/mg protein) when compared to inactive HDL from four patients with extrahepatic obstructive jaundice (1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] give complete reversal to discocytes (B). Echinocytes from a patient with alcoholic cirrhosis also returned towards a normal erythrocyte shape when similarly incubated with normal HDL; the percentage of echinocytes II and III present were reduced from 14% (C) to zero (D).
HDL, far less echinocytosis occurred when the incubations were repeated at 00C (Fig. 5) . Echinocytes formed by exposure to bile salts reverted to discocytes after three washes with Hanks' solution; those generated by lysolecithin or by patient HDL did not revert. Washed echinocytes produced by lysolecithin acquired a more normal shape after 7-8 h of incubation, presumably because lysolecithin progressively entered the inner membrane leaflet (31), but those produced by patient HDL did not reverse. VLDL, LDL, HDL, and LPDS were prepared from plasma enriched with lysolecithin or bile salts and washed once by ultracentrifugation, and their volumes were adjusted to that of the original plasma sample. Only the LPDS fractions were found to be echinocytogenic; the HDL produced <1% type II and III echinocytes.
These results seem to us to exclude lysolecithin and bile salts as the active constituents of echinocytogenic HDL. To assess whether other, so far unrecognized, amphipaths might be present we (reversibly) fixed a erythrocyte suspension in the discocytic shape with wheat germ agglutinin (17). Aliquots were incubated either with plasma enriched in lysolecithin or in bile salts (prepared as above) or with abnormal HDL. In each case echinocytosis was markedly inhibited, the number of type II and III echinocytes produced being reduced from 65-85% to 3-10%. Reagents were removed by washing three times with 50 vol of Hanks' buffer (without albumin) and then the bound lectin was dissociated by addition of N-acetylglucosamine. Cells exposed to lysolecithin became predominantly echinocytic; as expected, Albumin (mg / ml) Figure 9 . Inability of human serum albumin to prevent binding of liver disease HDL by erythrocytes. The patient HDL and incubation conditions were as described in Fig. 8 except that each tube contained up to 40 mg of defatted human serum albumin per milliliter, Final concentrations of patient HDL were either 31 ug of protein/ml (o) or the membrane of lectin-fixed cells took up the amphipath and retained it during washing and lectin dissociation. Cells treated with bile salts remained discocytic, because washing reverses bile salt-induced echinocytosis (unlike that induced by lysolecithin or by patient HDL, see above). Cells exposed to abnormal HDL remained largely discocytic, suggesting that abnormal HDL does not act by adding (or removing) lipophilic membrane constituents; it must occupy its receptors to be echinocytogenic.
Discussion
The literature on erythrocyte shape in liver disease is confused by inconsistent terminology. The term "spur cell," which should be reserved for acanthocytes, has often been used for spiculated cells, seen in vivo or generated in vitro, that are in fact echinocytes (as defined by Brecher and Bessis [9] (32) and vice versa (36). The shape ofcells loaded with cholesterol in our experiments, and in others (13, 27, 28) , bore little resemblance to the echinocytes ofjaundiced patients and could not be reversed by brief incubation with normal HDL. Cholesterol enrichment was evidently unrelated to echinocytosis induced in vitro by abnormal HDL, for the latter occurred in seconds, without increase in membrane cholesterol, and could also be induced by cholesterol-depleted HDL.
Two physiologic amphipaths producing echinocytes, lysolecithin and bile salts, were excluded as the active constituents of patient HDL; echinocytogenesis by these agents, and the properties of the resulting echinocytes, differed in several ways from those induced by abnormal HDL. Moreover, our experiments with wheat germ agglutinin tend to exclude other, so far unrecognized, amphipaths as echinocytic components of patient HDL, even were there evidence of their existence; in any case, the different properties of the echinocytes generated by known amphipaths renders such a mechanism unlikely. We (45) considered that only in patients with spur cells did morphologic alterations lead to the premature removal of cells (though their scanning electron micrograph of a spur cell showed an echinocyte). The hemoglo-bin levels in our patients did not correlate closely with the number of echinocytes in their blood. However, hemoglobin concentration in liver disease is altered by many factors (34) and the degree of hemolysis is best assessed by direct measurement.
Are echinocytes the precursors of acanthocytes as suggested by Grahn et al. (1) and Cooper et al. (46) and what is the mechanism for the conversion? The preponderance of echinocytes in our patients with spur cell anemia and with abetalipoproteinemia is consistent with such a precursor-product relationship. However, we believe the suggestion (13, 46) that, in liver disease, the conversion occurs in the spleen as a consequence of cholesterol enrichment must be viewed with caution. Evidence for a splenic conversion is derived from a single case (46) whereas, in other disorders, splenectomy can itself produce acanthocytosis (47). The relevance of cholesterol enrichment to acanthocytogenesis must also be questioned, as in abetalipoproteinemia the increase in cell cholesterol content is only marginal. It seems, therefore, that in liver disease the echinocytic shape, induced by abnormal HDL, may be a more critical factor to the conversion than the reductions in membrane fluidity (35) and cell deformability (13) caused by excess cholesterol. Clearly, additional studies are needed, both to establish the relationship between erythrocyte survival in liver disease and cell morphology and membrane lipid composition, and to understand in greater detail factors regulating erythrocyte shape in general.
